Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 9, 2010

Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success

Public Release of Alzheimer’s Clinical Trial Data by Pharmaceutical Researchers

Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases

A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trial

Critical Path Institute’s Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals an

March 23, 2010

First Annual Patient-Reported Outcome Consortium Workshop

March 23, 2010 Sheraton Silver Spring Hotel 8777 Georgia Avenue – Silver Spring, MD 20910 SPONSORED BY: Critical Path Instit

Critical Path Institute’s Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers

A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute&#8217

Urinary Biomarkers Trefoil Factor 3 and Albumin Enable Early Detection of Kidney Tubular Injury

Kidney injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies

Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development

A Panel of Urinary Biomarkers to Monitor Reversibility of Renal Injury and a Serum Marker with Improved Potential to Assess Renal Function

Previous104105 106...109 Next